STOP THE WAR! Let’s support Ukraine Together

Frazier Lifesciences (FLAC) to Combine with NewAmsterdam in $326M Deal

Frazier Lifesciences (FLAC) to Combine with NewAmsterdam in $326M Deal

Frazier Lifesciences  (NASDAQ:FLAC) has entered into a definitive agreement to combine with biotech firm NewAmsterdam Pharma Holding at an enterprise value of $326 million. Netherlands-based NewAmsterdam is developing a range of drugs aimed at reducing patient cholesterol levels suffering from liver, heart and brain disorders. The combined company is expected to trade on the Nasdaq
Read More

To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.